Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.
Patient assessment within the context of healthcare delivery packages: A comparative analysis.
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
A program to facilitate retention of employment among persons with multiple sclerosis.
Pseudoneoplasms in the nervous system.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
Multiple sclerosis: Gene-vitamin D interactions likely to influence pathogenesis and risk of relapse in multiple sclerosis.
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
Non-human primate models of multiple sclerosis.
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
Systematic review of correlates and determinants of physical activity in persons with multiple sclerosis.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.

Pages